白云山：子公司广州医药拟通过公开摘牌方式受让海正药业所持浙江医工100%股权，转让价款为5亿元

Core Viewpoint - The company Baiyunshan announced that its subsidiary Guangzhou Pharmaceutical intends to acquire 100% equity of Zhejiang Provincial Pharmaceutical Industry Co., Ltd. from Zhejiang Haizheng Pharmaceutical Co., Ltd. through a public transfer, with a transaction price of 500 million yuan [1] Group 1 - The acquisition involves a total equity transfer of Zhejiang Provincial Pharmaceutical Industry Co., Ltd. [1] - The transaction price is set at 500 million yuan [1] - The deal is subject to review by China's antitrust regulatory authority, indicating potential uncertainties [1]